3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Prostatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Melanoma
1
Kidney Neoplasms
1
Keratosis, Actinic
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
4
Imiquimod
3
VGX-3100
2
Conization
2
Colposcopy
2
Blood Specimen Collection
2
lime
1
hecolin
1
Vaginal Smears
1
Vaccines, Synthetic
1
Spectrometry, Fluorescence
1
Polymerase Chain Reaction
1
Papillomavirus Vaccines
1
Olive Oil
1
Mass Screening
1
Isotretinoin
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Hepatitis A Vaccines
1
Fluorouracil
1
Fenretinide
1
Electroporation
1
Cryosurgery
1
AKAP13 protein, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Uterine Cervical Dysplasia
×
Cryosurgery
×
Clear all
NCT00233727
2015-07-09
SAT
Columbia University
Phase 3
Terminated
7,123 enrolled